Atlas Trials

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients

Clinical trial NCT00826371 · COMPLETED

Trial details

NCT number
NCT00826371
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Age Related Macular Degeneration
Start date
2009-01-01
Primary completion
2010-07-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.